Miami, FL – April 3, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Reviv3 ProCare Co. (OTCQB: RVIV).

As more consumers migrate towards more natural solutions for hair and skin care, some “boutique brand” companies in this category have a unique opportunity to capture sizeable market share.

One company that may benefit from this migration is Reviv3 Procare (OTCQB: RVIV). The company initially launched its natural-based hair care product line in Italy, and later in New York, as an exclusive salon product but has recently initiated a successful direct-to-consumer marketing initiative in the U.S. The products focus on scalp health that, according to the company, is a foundation for healthy hair growth and a primary reason for the product’s effectiveness and success with consumers. 

Wall Street Journal article published on December 5th, 2019 and entitled Skin – and Hair-Care Products Lift Ulta Beauty’s Sales, highlights Ulta Beauty’s (NASDAQ: ULTA) new skin and hair care brands that according to Utla’s Chief Executive, Mary Dillion drove around 25% of the company’s total comparable sales in the latest quarter. That’s compared, however, to continued weakness in its make-up category that – according to securities filings – accounted for about 51% of the company’s total comparable sales for the fiscal year ended Feb 1, 2020.

See the WSJ article here and below:

Ulta’s total sales for the quarter rose roughly 8% from a year ago to $1.68 billion. Analysts had expected revenue of $1.69 billion.
PHOTO: GABBY JONES/BLOOMBERG NEWS

https://www.wsj.com/articles/skin-and-hair-care-products-lift-ulta-beautys-sales-11575593747

 

Ulta Beauty Inc. ULTA -0.09% posted higher sales in the latest quarter, driven by strength in the cosmetics company’s skin-care and hair-care categories.

Shares of Ulta Beauty rose 9% to $257.50 in after-hours trading following the results.

Skin care was one of the company’s strongest growth drivers, delivering double-digit comparable sales for the quarter, Chief Executive Mary Dillon said on a call with analysts.

“Much of this growth is a result of strong brand and product innovation as well as new skin-care routines,” Ms. Dillon said. New brands and products in skin care and hair care drove about 25% of the company’s total comparable sales, she said.

However, the company continues to see weakness in its makeup category, which accounted for about 51% of Ulta’s sales for the fiscal year ended Feb. 2, according to securities filings.

Total sales for the quarter rose roughly 8% from a year ago to $1.68 billion. Analysts had expected revenue of $1.69 billion. Comparable sales, a metric that includes stores open at least 14 months and the e-commerce business, rose 3.2% in the quarter, in line with analysts’ estimates, according to FactSet.

Rival Coty Inc.’s move last month to purchase a controlling stake in celebrity Kylie Jenner’s cosmetics startup, Kylie Cosmetics, has raised concerns that the deal could harm Ulta’s sales because Ulta started selling Kylie skin care products last year. However, Ulta’s executives assured analysts that it expects the partnership to continue, adding that the makeup assortment and approach were different.

“We have a great relationship with Coty, and we anticipate a lot of positive opportunity to continue to grow those brands together going forward,” Chief Financial Officer Scott Settersten said.

Ulta’s profit in the quarter fell to $129.7 million from $131.2 million a year ago. On a per-share basis, Ulta’s profit rose to $2.25, from $2.18, because of fewer shares outstanding, surpassing analysts’ profit estimate of $2.13.

The company also updated its earnings forecast, projecting full-year earnings between $11.93 to $12.03 a share, compared with its prior per-share outlook of $11.86 to $12.06.

Total sales are expected to increase by about 10%. In August, the company forecast total sales growth of between 9% and 12%. Meanwhile, the company narrowed its projected growth in comparable sales to 4.7%-5% from 4%-6% as it previously expected.

About EmergingGrowth.com

EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. EmergingGrowth.com has been compensated four thousand dollars in consideration for its work with Reviv3 Procare Co. through the date this was published. EmergingGrowth.com may or may not receive additional compensation, details about which can be found in our full disclosure, which can be found here, https://emerginggrowth.com/7848-68372/.  You can easily loose money investing in highly speculative small cap stocks like the ones mentioned within. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.comwebsite.

Add a Comment to this Post

comments